Ovid Therapeutics Stock Forward View - Triple Exponential Smoothing
| OVID Stock | USD 1.55 0.26 14.36% |
Ovid Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Ovid Therapeutics stock prices and determine the direction of Ovid Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ovid Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of Ovid Therapeutics' share price is approaching 48. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Ovid Therapeutics, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Using Ovid Therapeutics hype-based prediction, you can estimate the value of Ovid Therapeutics from the perspective of Ovid Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of Ovid Therapeutics on the next trading day is expected to be 1.54 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 3.96. Ovid Therapeutics after-hype prediction price | USD 1.55 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Ovid Therapeutics to cross-verify your projections. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.Ovid Therapeutics Additional Predictive Modules
Most predictive techniques to examine Ovid price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ovid using various technical indicators. When you analyze Ovid charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ovid Therapeutics Triple Exponential Smoothing Price Forecast For the 30th of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Ovid Therapeutics on the next trading day is expected to be 1.54 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.96.Please note that although there have been many attempts to predict Ovid Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ovid Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Ovid Therapeutics Stock Forecast Pattern
| Backtest Ovid Therapeutics | Ovid Therapeutics Price Prediction | Buy or Sell Advice |
Ovid Therapeutics Forecasted Value
In the context of forecasting Ovid Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ovid Therapeutics' downside and upside margins for the forecasting period are 0.02 and 7.58, respectively. We have considered Ovid Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Ovid Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Ovid Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0129 |
| MAD | Mean absolute deviation | 0.0671 |
| MAPE | Mean absolute percentage error | 0.0428 |
| SAE | Sum of the absolute errors | 3.96 |
Predictive Modules for Ovid Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ovid Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ovid Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Ovid Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ovid Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ovid Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ovid Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Ovid Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ovid Therapeutics' historical news coverage. Ovid Therapeutics' after-hype downside and upside margins for the prediction period are 0.08 and 7.59, respectively. We have considered Ovid Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ovid Therapeutics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Ovid Therapeutics is based on 3 months time horizon.
Ovid Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Ovid Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ovid Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ovid Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 6.04 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.55 | 1.55 | 0.00 |
|
Ovid Therapeutics Hype Timeline
Ovid Therapeutics is now traded for 1.55. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ovid is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.35%. %. The volatility of related hype on Ovid Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 1.55. About 34.0% of the company shares are owned by institutional investors. The book value of Ovid Therapeutics was now reported as 0.63. The company recorded a loss per share of 0.5. Ovid Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Ovid Therapeutics to cross-verify your projections. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.Ovid Therapeutics Related Hype Analysis
Having access to credible news sources related to Ovid Therapeutics' direct competition is more important than ever and may enhance your ability to predict Ovid Therapeutics' future price movements. Getting to know how Ovid Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ovid Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CNTX | Context Therapeutics | 0.00 | 0 per month | 3.16 | 0.28 | 9.59 | (5.51) | 20.53 | |
| MGNX | MacroGenics | 0.00 | 0 per month | 3.44 | 0.06 | 6.83 | (5.56) | 23.75 | |
| CLNN | Clene Inc | 0.00 | 0 per month | 0.00 | (0.21) | 7.41 | (15.07) | 38.74 | |
| ORMP | Oramed Pharmaceuticals | 0.00 | 0 per month | 1.96 | 0.19 | 6.98 | (3.49) | 17.67 | |
| STTK | Shattuck Labs | 0.00 | 0 per month | 2.87 | 0.26 | 6.42 | (4.55) | 27.07 | |
| IMA | ImageneBio | 0.00 | 0 per month | 0.00 | (0.07) | 6.76 | (5.08) | 16.10 | |
| CNTB | Connect Biopharma Holdings | 0.00 | 0 per month | 3.86 | 0.12 | 11.89 | (6.42) | 36.83 | |
| IFRX | InflaRx NV | 0.00 | 0 per month | 0.00 | (0.1) | 7.00 | (9.17) | 43.11 | |
| WHWK | Whitehawk Therapeutics | 0.00 | 0 per month | 3.61 | 0.05 | 6.98 | (6.28) | 21.49 | |
| KLRS | Kalaris Therapeutics | 0.00 | 0 per month | 4.34 | 0.17 | 15.58 | (8.21) | 32.70 |
Other Forecasting Options for Ovid Therapeutics
For every potential investor in Ovid, whether a beginner or expert, Ovid Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ovid Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ovid. Basic forecasting techniques help filter out the noise by identifying Ovid Therapeutics' price trends.Ovid Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ovid Therapeutics stock to make a market-neutral strategy. Peer analysis of Ovid Therapeutics could also be used in its relative valuation, which is a method of valuing Ovid Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Ovid Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Ovid Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ovid Therapeutics shares will generate the highest return on investment. By undertsting and applying Ovid Therapeutics stock market strength indicators, traders can identify Ovid Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 82987.19 | |||
| Daily Balance Of Power | (2.89) | |||
| Rate Of Daily Change | 0.86 | |||
| Day Median Price | 1.55 | |||
| Day Typical Price | 1.55 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.26) | |||
| Relative Strength Index | 48.49 |
Ovid Therapeutics Risk Indicators
The analysis of Ovid Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ovid Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ovid stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.22 | |||
| Semi Deviation | 4.86 | |||
| Standard Deviation | 6.04 | |||
| Variance | 36.42 | |||
| Downside Variance | 31.14 | |||
| Semi Variance | 23.66 | |||
| Expected Short fall | (5.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Ovid Therapeutics
The number of cover stories for Ovid Therapeutics depends on current market conditions and Ovid Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ovid Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ovid Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ovid Therapeutics Short Properties
Ovid Therapeutics' future price predictability will typically decrease when Ovid Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ovid Therapeutics often depends not only on the future outlook of the potential Ovid Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ovid Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.9 M | |
| Cash And Short Term Investments | 53.1 M |
Check out Historical Fundamental Analysis of Ovid Therapeutics to cross-verify your projections. For information on how to trade Ovid Stock refer to our How to Trade Ovid Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Will Stock sector continue expanding? Could Ovid diversify its offerings? Factors like these will boost the valuation of Ovid Therapeutics. Anticipated expansion of Ovid directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ovid Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Ovid Therapeutics's market price often diverges from its book value, the accounting figure shown on Ovid's balance sheet. Smart investors calculate Ovid Therapeutics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Ovid Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Ovid Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ovid Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Ovid Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.